Cardlytics (CDLX) to Release Quarterly Earnings on Wednesday

Cardlytics (NASDAQ:CDLX) is scheduled to release its earnings data after the market closes on Wednesday, May 8th. Cardlytics has set its Q1 2024 guidance at EPS.Parties that wish to register for the company’s conference call can do so using this link.

Cardlytics (NASDAQ:CDLX) last released its quarterly earnings data on Thursday, March 14th. The company reported ($0.14) earnings per share (EPS) for the quarter. Cardlytics had a negative net margin of 43.56% and a negative return on equity of 25.38%. The company had revenue of $89.17 million for the quarter.

Cardlytics Price Performance

Shares of NASDAQ CDLX opened at $15.20 on Tuesday. Cardlytics has a 1-year low of $4.94 and a 1-year high of $20.52. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 1.91. The business’s fifty day moving average price is $12.23 and its two-hundred day moving average price is $9.68.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. Needham & Company LLC upped their price objective on shares of Cardlytics from $15.00 to $17.00 and gave the stock a “buy” rating in a report on Tuesday, April 9th. Lake Street Capital raised their price objective on shares of Cardlytics from $13.00 to $18.00 and gave the company a “buy” rating in a research note on Friday, March 15th. Finally, Craig Hallum upgraded Cardlytics from a “hold” rating to a “buy” rating and upped their target price for the stock from $10.00 to $18.00 in a research report on Friday, March 15th.

Insider Buying and Selling

In related news, COO Amit Gupta sold 23,416 shares of the firm’s stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $11.91, for a total transaction of $278,884.56. Following the completion of the sale, the chief operating officer now directly owns 122,676 shares in the company, valued at $1,461,071.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, insider Nicholas Hollmeyer Lynton sold 12,460 shares of Cardlytics stock in a transaction on Tuesday, April 2nd. The stock was sold at an average price of $13.69, for a total value of $170,577.40. Following the transaction, the insider now directly owns 71,355 shares in the company, valued at approximately $976,849.95. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Amit Gupta sold 23,416 shares of the company’s stock in a transaction on Wednesday, April 24th. The shares were sold at an average price of $11.91, for a total value of $278,884.56. Following the sale, the chief operating officer now directly owns 122,676 shares of the company’s stock, valued at $1,461,071.16. The disclosure for this sale can be found here. Insiders have sold 36,306 shares of company stock worth $455,203 in the last ninety days. 4.40% of the stock is currently owned by corporate insiders.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.